首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   13190篇
  免费   1394篇
  国内免费   333篇
耳鼻咽喉   162篇
儿科学   378篇
妇产科学   246篇
基础医学   736篇
口腔科学   137篇
临床医学   1640篇
内科学   2877篇
皮肤病学   171篇
神经病学   610篇
特种医学   443篇
外国民族医学   2篇
外科学   1884篇
综合类   1623篇
现状与发展   2篇
预防医学   1171篇
眼科学   142篇
药学   1307篇
  66篇
中国医学   697篇
肿瘤学   623篇
  2024年   101篇
  2023年   558篇
  2022年   922篇
  2021年   1366篇
  2020年   1240篇
  2019年   1029篇
  2018年   969篇
  2017年   788篇
  2016年   643篇
  2015年   558篇
  2014年   1119篇
  2013年   1038篇
  2012年   675篇
  2011年   643篇
  2010年   468篇
  2009年   439篇
  2008年   407篇
  2007年   370篇
  2006年   312篇
  2005年   234篇
  2004年   188篇
  2003年   126篇
  2002年   112篇
  2001年   77篇
  2000年   58篇
  1999年   49篇
  1998年   54篇
  1997年   56篇
  1996年   45篇
  1995年   33篇
  1994年   24篇
  1993年   33篇
  1992年   23篇
  1991年   22篇
  1990年   19篇
  1989年   18篇
  1988年   14篇
  1987年   12篇
  1986年   9篇
  1985年   17篇
  1984年   15篇
  1983年   7篇
  1982年   9篇
  1981年   5篇
  1980年   2篇
  1978年   3篇
  1977年   3篇
  1975年   1篇
  1972年   1篇
  1971年   1篇
排序方式: 共有10000条查询结果,搜索用时 250 毫秒
101.
102.
103.
104.
105.
106.
107.
For women with breast cancer in whom multiple Oncotype DX® Recurrence Scores (RS) are obtained, RS concordance utilizing current NCCN recommendations has not been evaluated. Patients with two or more RS were identified. RS were stratified by NCCN guidelines and compared for concordance. Twenty-four patients were evaluated. RS concordance varied by tumor type: 100% in the same tumor, 91.7% in multiple ipsilateral tumors, 71.4% in contralateral tumors, and 66.7% in in-breast recurrent tumors. RS concordance for multiple assays in the same patient is not high enough to omit Oncotype DX® testing for each tumor.  相似文献   
108.
109.
110.
BackgroudDue to extensive fibrosis during revision surgery, adequate exposure is essential and it can be achieved with several extensile approach options, such as tibial tubercle osteotomy. Information regarding surgical exposure during revision arthroplasty is limited in developing countries, such as Pakistan, due to the lack of adequate data collection and follow-up. Therefore, the purpose of this study was to evaluate the impact of tibial tubercle osteotomy on final outcome of revision total knee arthroplasty (TKA).MethodsA total of 231 revision TKAs were performed between January 2008 and December 2017. Twenty-nine patients underwent tibial tubercle osteotomy for adequate exposure during revision surgery. Of these, 27 patients with complete follow-up were included in our study. Factors examined include age at the time of revision surgery, gender, comorbidities, arthroplasty site (right or left), body mass index (BMI), and primary indications for the tibial tubercle osteotomy during revision TKA. Functional outcome was measured by using Knee Society score (KSS) at 3 months and the final follow-up. All statistical analysis was done using SPSS version 20.0 with a p-value < 0.05 considered significant.ResultsOut of 27 patients, 6 patients (22.2%) were men and 21 patients (77.7%) were women. Right knee revision arthroplasty was performed in 15 patients (55.5%), left knee revision arthroplasty was performed in 12 patients (44.4%), and bilateral revision surgery was performed in only 1 patient (3.7%). The mean BMI was 29.2 kg/m2. We used a constrained condylar knee in 20 patients (74%), a rotating hinge knee in 5 patients (18.5%), and mobile bearing tray plus metaphyseal sleeves in 2 patients (7.4%). The KSS was 52.21 ± 4.05 preoperatively, and 79.42 ± 2.2 and 80.12 ± 1.33 at 3 months and 12 months, respectively. Radiological union was achieved in all patients at 3 months. Of 27 patients, only 1 patient (3.7%) had proximal migration of the osteotomy site at 6 months: the patient was asymptomatic and union was also achieved and, therefore, no surgical intervention was performed.ConclusionsTibial tubercle osteotomy during revision TKA can be a safe and reliable technique with superior outcomes and minimal complication rates.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号